Beth Grous's most recent trade in Generate Biomedicines Inc was a trade of 114,020 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Generate Biomedicines Inc | Beth Grous | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 114,020 | 114,020 | - | - | Stock Option (Right to Buy) | |
| Generate Biomedicines Inc | Beth Grous | Chief People Officer | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 26 Feb 2026 | 300 | 300 | - | 16 | 4,800 | Common Stock |